Market Overview

UPDATE: JP Morgan Initiates Greenway Medical Technologies at Overweight on Platform Quality

Related GWAY
Market Wrap For Tuesday, September 24: Markets Go Parabolic
Mid-Afternoon Market Update: Carnival Sinks on Weak Guidance; Markets Go Into The Red

JP Morgan initiated coverage on Greenway Medical Technologies (NYSE: GWAY) with an Overweight rating and a $19 price target.

JP Morgan noted, "We are initiating coverage on Greenway (GWAY) with an Overweight rating as we believe the company has a highly rated, differentiated platform from which to gain additional EMR, RCM and PM customers. Additionally, we believe Greenway's pro-active partnerships with enterprise EHRs provide an advantage for physicians."

Greenway Medical Technologies closed at $15.98 on Wednesday.

Latest Ratings for GWAY

DateFirmActionFromTo
Sep 2013Raymond JamesDowngradesStrong BuyMarket Perform
Sep 2013KeyBancDowngradesBuyHold
Sep 2013William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for GWAY
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (GWAY)

Around the Web, We're Loving...

Get Benzinga's Newsletters